231 related articles for article (PubMed ID: 14985099)
1. A bivalent single-chain Fv fragment against CD47 induces apoptosis for leukemic cells.
Kikuchi Y; Uno S; Yoshimura Y; Otabe K; Iida S; Oheda M; Fukushima N; Tsuchiya M
Biochem Biophys Res Commun; 2004 Mar; 315(4):912-8. PubMed ID: 14985099
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis inducing bivalent single-chain antibody fragments against CD47 showed antitumor potency for multiple myeloma.
Kikuchi Y; Uno S; Kinoshita Y; Yoshimura Y; Iida S; Wakahara Y; Tsuchiya M; Yamada-Okabe H; Fukushima N
Leuk Res; 2005 Apr; 29(4):445-50. PubMed ID: 15725479
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of a monoclonal antibody against CD47 in xenograft models of human leukemia.
Uno S; Kinoshita Y; Azuma Y; Tsunenari T; Yoshimura Y; Iida S; Kikuchi Y; Yamada-Okabe H; Fukushima N
Oncol Rep; 2007 May; 17(5):1189-94. PubMed ID: 17390064
[TBL] [Abstract][Full Text] [Related]
4. A new disulfide-linked dimer of a single-chain antibody fragment against human CD47 induces apoptosis in lymphoid malignant cells via the hypoxia inducible factor-1α pathway.
Sagawa M; Shimizu T; Fukushima N; Kinoshita Y; Ohizumi I; Uno S; Kikuchi Y; Ikeda Y; Yamada-Okabe H; Kizaki M
Cancer Sci; 2011 Jun; 102(6):1208-15. PubMed ID: 21401803
[TBL] [Abstract][Full Text] [Related]
5. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.
Nielsen UB; Adams GP; Weiner LM; Marks JD
Cancer Res; 2000 Nov; 60(22):6434-40. PubMed ID: 11103810
[TBL] [Abstract][Full Text] [Related]
6. Development and characterization of three recombinant single chain antibody fragments (scFvs) directed against the CD19 antigen.
Bejcek BE; Wang D; Berven E; Pennell CA; Peiper SC; Poppema S; Uckun FM; Kersey JH
Cancer Res; 1995 Jun; 55(11):2346-51. PubMed ID: 7538901
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment.
Arndt KM; Müller KM; Plückthun A
Biochemistry; 1998 Sep; 37(37):12918-26. PubMed ID: 9737871
[TBL] [Abstract][Full Text] [Related]
8. Target cell-restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7.
Bremer E; Samplonius DF; Peipp M; van Genne L; Kroesen BJ; Fey GH; Gramatzki M; de Leij LF; Helfrich W
Cancer Res; 2005 Apr; 65(8):3380-8. PubMed ID: 15833872
[TBL] [Abstract][Full Text] [Related]
9. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
Biburger M; Weth R; Wels WS
J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
Wang X; Campoli M; Ko E; Luo W; Ferrone S
J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
[TBL] [Abstract][Full Text] [Related]
11. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
[TBL] [Abstract][Full Text] [Related]
12. Mono and bivalent binding of a scFv and covalent diabody to murine laminin-1 using radioiodinated proteins and SPR measurements: effects on tissue retention in vivo.
Huang BC; Davern S; Kennel SJ
J Immunol Methods; 2006 Jun; 313(1-2):149-60. PubMed ID: 16750217
[TBL] [Abstract][Full Text] [Related]
13. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
Wang Y; Li X; Chen W
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168
[TBL] [Abstract][Full Text] [Related]
14. Gene cloning, bacterial expression, in vitro refolding, and characterization of a single-chain Fv antibody against PreS1(21-47) fragment of HBsAg.
Yang X; Hu W; Li F; Xia H; Zhang Z
Protein Expr Purif; 2005 Jun; 41(2):341-8. PubMed ID: 15866720
[TBL] [Abstract][Full Text] [Related]
15. Monovalent single-chain Fv fragments and bivalent miniantibodies bound to vesicular stomatitis virus protect against lethal infection.
Kalinke U; Krebber A; Krebber C; Bucher E; Plückthun A; Zinkernagel RM; Hengartner H
Eur J Immunol; 1996 Dec; 26(12):2801-6. PubMed ID: 8977271
[TBL] [Abstract][Full Text] [Related]
16. Expression and functional analysis of recombinant scFv and diabody fragments with specificity for human RhD.
Asvadi P; Fletcher A; Raison RL
J Mol Recognit; 2002; 15(5):321-30. PubMed ID: 12447910
[TBL] [Abstract][Full Text] [Related]
17. Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics.
Kipriyanov SM; Moldenhauer G; Schuhmacher J; Cochlovius B; Von der Lieth CW; Matys ER; Little M
J Mol Biol; 1999 Oct; 293(1):41-56. PubMed ID: 10512714
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of tumor growth and metastasis of human melanoma by intracellular anti-ATF-1 single chain Fv fragment.
Jean D; Tellez C; Huang S; Davis DW; Bruns CJ; McConkey DJ; Hinrichs SH; Bar-Eli M
Oncogene; 2000 May; 19(22):2721-30. PubMed ID: 10851072
[TBL] [Abstract][Full Text] [Related]
19. [Construction and expression of single chain variable fragments (ScFv) against human CD19 antigen].
Chen S; Rao Q; Wang JX; Wang M
Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):686-91. PubMed ID: 16285505
[TBL] [Abstract][Full Text] [Related]
20. Production and characterization of an active single-chain variable fragment antibody recognizing CD25.
Muramatsu H; Yoshikawa K; Hayashi T; Takasu S; Kawada Y; Uchida K; Sato S; Takahashi T; Saga S; Ueda R
Cancer Lett; 2005 Jul; 225(2):225-36. PubMed ID: 15978327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]